Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Prof. Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Director at Swallowing Center/The University of Tokyo Hospital, Japan

Dr. Rumi Ueha is a distinguished specialist in otolaryngology, focusing on airway surgery, swallowing disorders, and olfactory disorders. Holding both an M.D. and Ph.D., Dr. Ueha has accumulated significant expertise through her academic and clinical career. She has contributed extensively to the medical field, particularly in research concerning dysphagia, pediatric airway, chronic airway inflammation, and the regeneration of olfactory receptor cells. Dr. Ueha’s leadership is evident through her current position as Director and Associate Professor at the University of Tokyo, where she combines research, clinical practice, and mentorship. She is internationally recognized for her research in swallowing surgery and airway management, frequently collaborating with institutions across Japan and globally.

Professional Profile

Education:

Dr. Ueha earned her M.D. from the University of Tokyo in 2003, followed by her Ph.D. in 2017, also from the University of Tokyo. Her educational journey includes extensive training in otolaryngology and head and neck surgery, with specialized fellowships in broncho-esophagology. She has studied at renowned institutions, such as the University of California, Davis, and the University of Michigan, further solidifying her academic foundation. This rigorous education laid the groundwork for her research into complex disorders involving the airway, swallowing, and olfaction.

Professional Experience:

Dr. Ueha’s professional journey spans various prestigious roles, beginning as a resident and fellow in otolaryngology at the University of Tokyo and NTT Medical Center. Over the years, she advanced through key positions such as Assistant Professor and Project Lecturer, before being appointed as Director and Associate Professor. Her clinical and research work at the Swallowing Center of the University of Tokyo Hospital has contributed to groundbreaking advancements in dysphagia and swallowing surgery. She has also held visiting researcher roles, expanding her global network and research opportunities.

Research Interests:

Dr. Ueha’s research primarily focuses on the medical and surgical management of swallowing disorders (dysphagia), airway surgery, and olfactory disorders. She is particularly interested in swallowing surgery, chronic airway inflammation, and esophageal dysmotility. Dr. Ueha has explored innovative approaches in airway virtual reality, voice surgery, and pediatric airway management. Additionally, her work in olfactory receptor cell regeneration and the effects of aging on the olfactory system highlights her commitment to advancing treatment options for patients with sensory impairments. Her research also investigates the impact of SARS-CoV-2 on these systems.

Research Skills:

Dr. Ueha’s research skills are broad and multidisciplinary, combining clinical expertise with innovative technologies. She has demonstrated advanced knowledge in airway surgery, swallowing rehabilitation, and neurophysiology. Her skills also extend to virtual reality applications for airway management, showing her adaptability to emerging technologies. Dr. Ueha excels in clinical trials, with a focus on neuromuscular diseases and their impact on swallowing. Her ability to conduct translational research that bridges laboratory findings with clinical applications has led to advancements in treating complex airway and swallowing conditions.

Awards and Honors:

Dr. Ueha has received numerous prestigious awards in recognition of her contributions to otolaryngology and research. These include the Woman Award 2024 by the Oto-Rhino-Laryngological Society of Japan and the Excellence Award at the 16th Scientific Meeting of the Japanese Society of Anti-Aging Medicine. She has also been honored with several first-place prizes, including those for her management improvement projects at the University of Tokyo Hospital. Her recognition in the academic community extends to multiple journal editorial board positions, including for Auris Nasus Larynx and the Japanese Journal of Rhinology, where she influences advancements in her field.

Conclusion:

Dr. Rumi Ueha is a highly accomplished researcher and academic leader in the field of otolaryngology, particularly in swallowing disorders and airway surgery. Her strong academic background, multiple accolades, and extensive international experience make her an outstanding candidate for the Best Researcher Award. While further efforts in research funding and interdisciplinary collaborations would elevate her work, her substantial contributions to her field position her as a leader in otolaryngology and swallowing research.

Publication Top Notes

  • English as a Foreign Language Instructors’ Questioning Behaviors and Strategy Uses for Reflective Learning Facilitation
    • Authors: Not specified
    • Year: Not specified
  • A Narrative Review of Basic and Clinical Studies for Vocal Fold Regeneration Therapies
    • Authors: Cathrine Miura, Rumi Ueha, Maria Angela Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1016/j.anl.2024.10.011
  • A Retrospective Study of Cricotracheostomy: Indications, Techniques, and Clinical Outcomes
    • Authors: Kana Nanjo, Rumi Ueha, Maria A. Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1002/ohn.1053
  • Swallowing Virtual Reality as a Novel Diagnostic Tool for Severe Dysphagia After Deep Neck Infection: A Case Report
    • Authors: Takahiro Katsuno, Rumi Ueha, Kana Nanjyo, Kazuaki Matsuda, Cathrine Miura, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.21203/rs.3.rs-4725568/v1
  • Esophageal Dysmotility in Multiple System Atrophy: A Retrospective Cross-Sectional Study
    • Authors: Rumi Ueha, Misaki Koyama, Akiko Seto, Taku Sato, Takao Goto, Kenta Orimo, Jun Mitsui, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.3390/jcm13175026
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report
    • Authors: Carmel Cotaoco, Takao Goto, Misaki Koyama, Taku Sato, Kenji Kondo, Rumi Ueha
    • Year: 2024
    • DOI: 10.1007/s42399-024-01713-2
  • Swallowing Improvement Surgeries
    • Authors: Carmel Cotaoco, Rumi Ueha, Misaki Koyama, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1007/s00405-024-08452-z
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report (Preprint)
  • Use of CT for Dysphagia Evaluation: Advantages and Disadvantages in the Study of Swallowing
  • Three-Dimensional Computed Tomography Features of Recurrent Laryngeal Nerve Paralysis Due to Aortic Aneurysm
    • Authors: Jumpei Sasakawa, Takao Goto, Taku Sato, Misaki Koyama, Rumi Ueha, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.1007/s42399-024-01685-3

 

 

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3